Vaccsys Raises $9M in Series A
Gregory T. Huang6/19/08
Vaccsys, a vaccine maker based in Seattle, has called down $9 million of an $18 million Series A round, according to Private Equity Hub, which cites a regulatory filing. The investors include Alta Partners, The Column Group, and Versant Ventures (all based in California).
Gregory T. Huang is Xconomy's National IT Editor and the Editor of Xconomy Boston. You can e-mail him at gthuang@xconomy.com, call him at 617-252-7323, or follow him on Twitter at @gthuang.
